TCG Crossover Management »

ADC Therapeutics SA shares owned by TCG Crossover Management

Quarter-by-quarter ownership of ADC Therapeutics SA (ADCT) shares owned by TCG Crossover Management from 13F filings

Historical chart of TCG Crossover Management investment in ADC Therapeutics SA

Tip: Access up to 7 years of quarterly data

All positions including ADC Therapeutics SA held by TCG Crossover Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ADC Therapeutics SA by TCG Crossover Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $5.6M 1.4M 4.00

More positions owned by TCG Crossover Management

Abivax Sa American Depositary Shares Adrs (ABVX)
Cg Oncology Comm (CGON)
Cogent Biosciences Comm (COGT)
Amylyx Pharmaceuticals Comm (AMLX)
Centessa Pharmaceuticals Adrs (CNTA)
Tango Therapeutics Comm (TNGX)
Ocular Therapeutix Comm (OCUL)
Dianthus Therapeutics Comm (DNTH)
Tourmaline Bio Comm (TRML)
Dyne Therapeutics Comm (DYN)
Agios Pharmaceuticals Comm (AGIO)
Eyepoint Pharmaceuticals Comm (EYPT)
Fulcrum Therapeutics Comm (FULC)
Savara Comm (SVRA)
Rapt Therapeutics Comm (RAPT)

View all positions for TCG Crossover Management

Top funds holding ADC Therapeutics SA

Redmile Group
Point72 Asset Management
Prosight Management
OrbiMed Advisors
BlackRock
Morgan Stanley
Nantahala Capital Management
Goldman Sachs Group
TCG Crossover Management
Lynx1 Capital Management
State Street Corporation
Platinum Investment Mangement
Geode Capital Management
Citadel Advisors
Blue Owl Capital Holdings

View all funds holding ADC Therapeutics SA